WAT · Waters Corp
Price
Snapshot
50 fields · last close| Market Cap | $43.78B |
| P/E | 263.53 |
| Float | 98.08M |
| Beta | 1.16 |
| Volatility | 29.1% |
| Exchange | NYSE |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80.4 |
| Price | 434.20 |
| Change | −0.63% |
| Prev Close | 436.95 |
| Open | 444.48 |
| Day Low | 431.99 |
| Day High | 448.39 |
| Avg Vol | 1 |
| Avg $ Vol | $427.8M |
| 52W High | 454.54 |
| 52W Low | 282.77 |
| 52W Pos | 88.2% |
| From High | −4.47% |
| From Low | +53.55% |
| Max DD 1Y | −31.32% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +0.22% |
| SMA 50 | +3.25% |
| SMA 200 | +18.56% |
| RSI (14) | 55.9 |
| Vol 30D | 24.4% |
| Vol 90D | 26.1% |
| 1Y Range | 283–455 |
| Daily bars | 536 |
| Perf Week | +0.73% |
| Perf Month | +1.68% |
| Perf Quarter | +22.21% |
| Perf Half Y | +33.31% |
| Perf Year | +31.45% |
| Perf YTD | +13.68% |
| Prev Day | −0.63% |
| Clavix | B+ |
| Debt / Eq | 0.55 |
| Curr Ratio | 1.73 |
| Int Cover | 2.6× |
| FCF Margin | 20.6% |
| Rev Growth | +7.0% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 3 / 19 |
What WAT does
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Clavix risk grade
regraded every trading dayWAT grades B+, 80.4 of 100. Steadiest on News Sentiment (68), most exposed on Price Stability (65, steady). 3 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 3 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| WAT | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.16 | 1.18 |
| Volatilityannualized | 29.1% | 29.4% |
| Max drawdown, past yearworst peak-to-trough fall | −31.3% | — |
| Typical daily movemedian absolute daily change | 1.08% | — |
| Days beyond ±3%of the last 252 sessions | 26 (10%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| WAT | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.16 | 1.18 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| WAT | |
|---|---|
| 1 week | +0.7% |
| 1 month | +1.7% |
| Year to date | +13.7% |
| 1 year | +31.4% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| WAT | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 30 Jun |
| Average score0 most bearish, 100 most bullish | 67 |
| Bullish · bearisharticles above 60 · below 40 | 24 · 3 |
| Directionarticles whose tone is improving vs worsening | 24 ↑ 3 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| WAT | |
|---|---|
| Revenue growthyear over year | +7.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openWaters Corporation announced the launch of Waters AI Link, a new software capability that connects its laboratory instruments to artificial intelligence systems, and said it has joined an Anthropic-led research program on hardware standards for AI agents.
Waters Corporation launched a software tool called AI Link that brings Anthropic's Model Context Protocol into its lab software, and joined Anthropic's Model Hardware Standard research program. The product is aimed at adding AI features across its liquid chromatography-mass spectrometry (LC-MS) workflows, which are instruments and software used to separate and identify chemicals in lab samples.
An analyst article recommends holding on to Waters Corporation (WAT) stock, citing growth from strong demand in analytical sciences, synergies from a BD (Becton Dickinson) acquisition, and ongoing innovation, while flagging continued weakness in China and risks from integrating the BD business.
Waters Corporation and CellCarta have agreed to work together on companion diagnostics, starting with programmes based on flow cytometry (a lab technique that sorts and analyses cells).
In mid-September 2026, Waters announced a partnership with Everlywell to support at-home HPV cervical cancer screening, and also launched the BD FACSDiscover A7 Cell Analyzer worldwide for research labs. Together these moves expand Waters' role in at-home diagnostics and advanced cell analysis.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| IQV | IQVIA Holdings Inc | B | $43.93B | 31.95 | 1.18 | Compare |
| ILMN | Illumina Inc | B- | $39.64B | 48.05 | 1.43 | Compare |
| A | Agilent Technologies Inc | B | $48.77B | 33.86 | 1.25 | Compare |
| MTD | Mettler-toledo International Inc | B+ | $32.51B | 35.89 | 1.19 | Compare |
| WST | West Pharmaceutical Services Inc | A- | $23.90B | 49.78 | 1.15 | Compare |
| MEDP | Medpace Holdings Inc | B | $17.26B | 35.12 | 1.11 | Compare |
| RVTY | Revvity Inc | B | $17.03B | 71.70 | 1.09 | Compare |
| CRL | Charles River Laboratories International Inc | B- | $14.33B | — | 1.37 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.